2-氨基-5-溴苯甲酰胺 | 16313-66-9

• 物质功能分类: 化学试剂 - 有机试剂 - 酰胺
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-氨基-5-溴苯甲酰胺
• 中文别名: 2-氨基-5-溴-苯甲酰胺
• 英文名称: 5-bromoanthranilamide
• 英文别名: 2-amino-5-bromobenzamide；5-Brom-anthranilamid
• CAS: 16313-66-9
• 化学式: C₇H₇BrN₂O
• mdl: MFCD04037881
• 分子量: 215.049
• InChiKey: LHAJKJQNMKXZSZ-UHFFFAOYSA-N

物化性质

• 熔点：
  189-191℃ (water ethanol )
• 沸点：
  291.2±25.0℃ (760 Torr)
• 密度：
  1.698±0.06 g/cm3 (20 ºC 760 Torr)
• 闪点：
  129.9±23.2℃

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  69.1
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2924299090
• 危险类别：
  IRRITANT
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302+H312+H332,H315,H319,H335
• 储存条件：
  2-8°C

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Amino-5-bromobenzamide
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Amino-5-bromobenzamide
CAS number: 16313-66-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H7BrN2O
Molecular weight: 215.0

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-氨基-5-溴苯甲酰胺 在 碘 、 三乙胺 、 三氯氧磷 作用下， 以 乙醇 为溶剂， 反应 13.0h， 生成 6-溴-4-氯喹唑啉
  参考文献：
  名称：

  4-（卤代苯胺基）-6-溴喹唑啉及其6-（4-氟苯基）取代衍生物作为表皮生长因子受体酪氨酸激酶的潜在抑制剂的合成及体外细胞毒性

  摘要：

  评估了一系列2-未取代和2-（4-氯苯基）-取代的4-苯胺基-6-溴喹唑啉及其6-（4-氟苯基）-取代的衍生物对MCF-7和HeLa细胞的体外细胞毒性。2-未取代的4-苯胺基-6-溴喹唑啉缺乏活性，而发现它们的大多数2-（4-氯苯基）取代的衍生物对HeLa细胞显示出显着的细胞毒性和选择性。与吉非替尼相比，用2-氟苯基取代2-未取代的4-苯胺基喹唑啉的溴导致对HeLa细胞的优异活性。除了3-氯苯胺基衍生物以外，在2-（4-氯苯基）取代的衍生物中存在4-氟苯基导致对HeLa细胞的细胞毒性增加。活性最高的化合物3g，3l和4l 被发现对表皮生长因子受体酪氨酸激酶（EGFR-TK）表现出中度至显着的抑制作用。EGFR分子对接模型表明这些化合物与EGFR区域结合良好。

  DOI：

  10.3390/ph10040087
• 作为产物：
  描述：

  5-溴靛红酸酐 在 ammonium carbonate 作用下， 以 1,4-二氧六环 为溶剂， 生成 2-氨基-5-溴苯甲酰胺
  参考文献：
  名称：

  蓝藻丙酮酸脱氢酶复合物E1抑制剂的设计，合成和效价

  摘要：

  需要安全有效的除藻剂来控制具有农业和环境意义的藻类。四个系列（6，10，17，和21 29新的4-氨基嘧啶衍生物）的合理设计和合成。的一部分10，17，和21中显示的有效抑制大肠杆菌丙酮酸脱氢酶复合物E1（大肠杆菌PDHC-E1）（IC 50 = 2.12-18.06μM）和抑制良好的集胞藻属。PCC 6803（EC 50 = 0.7–7.1μM）和微囊藻。FACH 905（EC 50= 3.7–7.6μM）。这些化合物的杀藻活性与它们对大肠杆菌PDHc-E1的抑制作用正相关。特别是21l和10b表现出对PCC 6803的强效杀藻活性（分别为EC 50 = 0.7和0.8μM），其值是硫酸铜（EC 50 = 1.8μM）的2倍，并且表现最佳抑制蓝细菌PDHc-E1（IC 50分别为5.10和6.06μM ）。17h和21e是大肠杆菌的最佳抑制剂通过分子对接，定点诱变和酶促测定研究了PDHc

  DOI：

  10.1021/acs.biochem.7b00636

文献信息

• [EN] QUINAZOLINES USEFUL AS MODULATORS OF ION CHANNELS<br/>[FR] QUINAZOLINES UTILISEES COMME MODULATEURS DE CANAUX IONIQUES
  申请人：VERTEX PHARMA

  公开号：WO2004078733A1

  公开（公告）日：2004-09-16

  The present invention relates to quinazoline compounds of formula (I) useful as inhibitors of voltage-gated sodium channels and calcium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders. or a pharmaceutically acceptable derivative thereof, wherein R1, X, R3, x, and ring A are as defined in the present application.

  本发明涉及式（I）的喹唑啉化合物，其作为电压门控钠通道和钙通道的抑制剂。该发明还提供了包括本发明化合物的药学上可接受的组合物，以及使用这些组合物治疗各种疾病的方法。或其药学上可接受的衍生物，其中R1、X、R3、x和环A如本申请中所定义。
• [EN] NOVEL ANTI-INFLAMMATORY AGENTS<br/>[FR] NOUVEAUX AGENTS ANTI-INFLAMMATOIRES
  申请人：RESVERLOGIX CORP

  公开号：WO2010123975A1

  公开（公告）日：2010-10-28

  Disclosed are methods of regulating interleukin-6 (IL-6) and/or vascular cell adhesion molecule-1 (VCAM-1) and methods of treating and/or preventing cardiovascular and inflammatory diseases and related disease states, such as, for example, atherosclerosis, asthma, arthritis, cancer, multiple sclerosis, psoriasis, and inflammatory bowel diseases, and autoimmune disease(s) by administering a naturally occurring or synthetic quinazolone derivative. The invention provides novel synthetic quinazolone compounds, as well as pharmaceutical compositions comprising those compounds.

  揭示了调节白细胞介素-6（IL-6）和/或血管细胞粘附分子-1（VCAM-1）的方法，以及治疗和/或预防心血管和炎症性疾病及相关疾病状态的方法，例如动脉粥样硬化、哮喘、关节炎、癌症、多发性硬化、牛皮癣和炎症性肠病以及自身免疫疾病，通过给予天然存在或合成的喹唑啉衍生物。该发明提供了新颖的合成喹唑啉化合物，以及包含这些化合物的药物组合物。
• Iron nitrate/TEMPO-catalyzed aerobic oxidative synthesis of quinazolinones from alcohols and 2-aminobenzamides with air as the oxidant
  作者：Yongke Hu、Lei Chen、Bindong Li

  DOI：10.1039/c6ra12164k

  日期：——

  A highly efficient, Iron nitrate/TEMPO-catalyzed approach for the synthesis of quinazolinones has been achieved via a one-pot, tandem aerobic oxidative cyclization of primary alcohols with 2-aminobenzamides. This practical reaction tolerates...

  高效，硝酸铁/ TEMPO催化合成喹唑啉酮的方法是通过伯醇与2-氨基苯甲酰胺的一锅串联串联好氧氧化环化反应而实现的。这种实际反应可以容忍...
• Visible light induced tandem reactions: An efficient one pot strategy for constructing quinazolinones using in-situ formed aldehydes under photocatalyst-free and room-temperature conditions
  作者：Zongbo Xie、Jin Lan、Haibo Zhu、Gaoyi Lei、Guofang Jiang、Zhanggao Le

  DOI：10.1016/j.cclet.2020.09.059

  日期：2021.4

  aminobenzamides and in-situ generated aldehydes. Visible light was found to play a dual role: first oxidizes the alcohol to the aldehyde and then facilitates its cyclization with o-substituted aniline. Furthermore, alcohols are perfect alternatives to aldehydes because they are greener, more available, more economical, more stable, and less toxic than aldehydes. The first reaction step continuously

  已经开发了一种从各种氨基苯甲酰胺和原位生成的醛构建喹唑啉酮的简便串联途径。发现可见光起着双重作用：首先将醇氧化成醛，然后促进其与邻苯二甲酸的环化。取代的苯胺。此外，醇是醛的完美替代品，因为它们比醛更绿色，更易得，更经济，更稳定且毒性更低。第一反应步骤连续地为第二步骤提供材料，该材料有效地减少了由于醛的挥发，氧化和聚合而造成的损失，同时避免了其毒性。可以在可见光存在下制备各种喹唑啉酮，而无需任何其他光催化剂。发达的合成方案具有温和条件，广泛的底物范围，操作简便和高原子效率的优点，并在无金属，无光催化剂和环境条件下具有生态能源。
• [EN] BRIDGED RING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF<br/>[FR] COMPOSÉS DE TYPE CYCLES À PONTS À TITRE D'INHIBITEURS DU VIRUS DE L'HÉPATITE C, COMPOSITIONS PHARMACEUTIQUES ET LEURS UTILISATIONS
  申请人：SUNSHINE LAKE PHARMA CO LTD

  公开号：WO2014131315A1

  公开（公告）日：2014-09-04

  Provided herein is a compound of formula (I) or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, which can be used for treating HCV infection or a HCV disorder. Also provided herein are a pharmaceutical composition comprising the compound and the use of the compound and the pharmaceutical composition thereof, which can also be used for treating HCV infection or a HCV disorder.

  本文提供的是一种化合物，其化学式为（I）或其立体异构体、几何异构体、互变异构体、N-氧化物、水合物、溶剂合物、代谢物、药用盐或其前药，可用于治疗HCV感染或HCV疾病。本文还提供了包含该化合物的药物组合物以及该化合物及其药物组合物的用途，也可用于治疗HCV感染或HCV疾病。